Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for spinal cord injury pain: drug targets nerve pain at its source

NCT ID NCT05639946

First seen Apr 08, 2026 · Last updated May 23, 2026 · Updated 10 times

Summary

This study tested whether the drug brivaracetam can reduce the severe nerve pain that many people with spinal cord injury experience. About 44 adults with chronic spinal cord injury and persistent nerve pain took either the drug or a placebo for several weeks. Researchers measured changes in pain intensity and how it affected daily activities, mood, and sleep.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

Conditions

Explore the condition pages connected to this study.